Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease-Reference-Cited by-同舟云学术

Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease

Published:2021-10-23 Issue:12 Volume:41 Page:998-1008
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

An Jaejin¹²^ORCID,Niu Fang³,Sim John J.²⁴

Affiliation:

1. Research & Evaluation, Kaiser Permanente Southern California Pasadena California USA

2. Kaiser Permanente Bernard J. Tyson School of Medicine Pasadena California USA

3. Drug Use Management Pharmacy Outcomes Research Group Kaiser Permanente Downey California USA

4. Division of Nephrology and Hypertension Kaiser Permanente Los Angeles Medical Center Los Angeles California USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

Reference25 articles.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献